Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
Abstract
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihydrotestosterone (DHT), leading to follicular miniaturization. While FDA-approved treatments like minoxidil and finasteride are standard, off-label therapies and emerging treatments continue to evolve. This systematic review examines the current and emerging treatment landscape for AGA, focusing on various topical, oral, injectable, and non-pharmacological interventions. Androgenetic Alopecia, Dihydrotestosterone (DHT), Hair Follicle Miniaturization, Finasteride and Minoxidil, AGA Emerging Therapies
Fields of Study & Subjects
Hair Growth and Disorders
Neurological diseases and metabolism
Lipid metabolism and disorders
Publication details
- Journal / source
- Journal of Drugs in Dermatology
- Publisher
- SanovaWorks
- Volume
- 25
- Issue
- 3
- Pages
- 240–245
- Publication date
- 1 February 2026
- Language
- EN